Uterine carcinoma in mice treated neonatally with Tamoxifen

Carcinogenesis

Volumn 18, Issue 12, 1997, Pages 2293-2298

  Newbold, Retha R ^a   Jefferson, Wendy N ^a   Padilla Burgos, Elizabeth ^a   Bullock, Bill C ^b  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; TAMOXIFEN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS LUTEUM; CYSTADENOMA; ENDOMETRIUM CARCINOMA; EPITHELIUM HYPERPLASIA; FEMALE; FETUS; HISTOPATHOLOGY; HORMONAL CARCINOGENESIS; HYPOPLASIA; MOUSE; NONHUMAN; OVARY; OVARY CYST; OVIDUCT; PRENATAL EXPOSURE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; UTERINE CERVIX; UTERUS CARCINOMA; UTERUS MALFORMATION; VAGINA; VAGINA ADENOSIS;

ADENOCARCINOMA; ANIMALS; ANIMALS, NEWBORN; ENDOMETRIAL NEOPLASMS; FALLOPIAN TUBES; FEMALE; MICE; OVARIAN CYSTS; TAMOXIFEN; UTERINE NEOPLASMS; VAGINAL DISEASES;

EID: 0031427596     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/18.12.2293     Document Type: Article

References (41)

1. IARC (1996) IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Some Pharmaceutical Drugs. IARC, Lyon, vol. 66, pp.253-365.
2. Ingle, J.N. (1984) Additive hormonal therapy in women with advanced breast cancer. Cancer, 53(3), 766-777.
3. Jordan, V.C. (1993) A current view of tamoxifen for the treatment and prevention of breast cancer. B. J. Pharmacal., 110, 507-517.
4. Riley, D., Baum, M., Macintyre, J. et al. (1992) The effect of adjuvant tamoxifen - The latest results from the Cancer Research Campaign adjuvant breast trial. E. J. Cancer, 28A, 904-907.
5. Jordan, V.C. (1995) Studies on the estrogen receptor in breast cancer -20 years as a target for the treatment and prevention of cancer. Breast Cancer Res. Treat., 36, 267-285.
6. Powles, T.J. (1992) The case for clinical trials of tamoxifen for prevention of breast cancer. Lancet, 340, 1145-1147.
7. Clark, S. (1993) Prophylactic tamoxifen. Lancet, 342, 168.
8. Cullins, S.L., Pridjian, G. and Sutherland, C.M. (1994) Goldenhar's syndrome associated with Tamoxifen given to the mother during gestation. J. Am. Med. Assoc., 271, 1905-1906.
9. Herbst, A.L. and Bern, H.A. (1981) Developmental Effects of Diethylstilbestrol (DES) in Pregnancy. Thieme-Stratton, New York.
10. Harper, M.J.K. and Walpole, A.L. (1966) Contrasting endocrine activities of cis and trans isomers in a series of substituted triphenylethylenes. Nature, 212, 87-88.
11. Iguchi, T. and Ohta, Y. (1996) Cellular effects of early tamoxifen. In Kellen, J.A. (eds) Tamoxifen, Beyond the Antiestrogen. Birkhauser, Boston, pp. 179-199.
12. Clark, J.H. and McCormack, S. (1977) Clomid or nafoxidine administered to neonatal rats causes reproductive tract abnormalities. Science, 197, 164-165.
13. McCormack, S. and Clark, J.H. (1979) Clomid administration to pregnant rats causes abnormalities of the reproductive tract in offspring and mothers. Science, 204, 629-631.
14. Clark, J.H., Guthrie, S.C. and McCormack, S.A. (1981) Neonatal stimulation of the uterus by clomiphene, tamoxifen, and nafoxidine: relationship to the development of reproductive tract abnormalities. Adv. Exp. Med. Biol., 138, 87-98.
15. Chamness, G.C., Bannayan, G.A., Landry, L.A. Jr., Sheridan, P.J. and McGuire, W.L. (1979) Abnormal reproductive development in rats after neonatally administered antioestrogen (tamoxifen). Biol. Reprod., 21, 1087-1090.
16. Holinka, C.F., Bressler, R.S., Zehr, D.R. and Gurpide, E. (1980) Comparison of effects of estertrol and tamoxifen with those of estriol and estradiol on the immature rat uterus. Biol. Reprod., 22, 913-926.
17. Branham, W.S., Zehr, D.R., Chen, J.J. and Sheehan, D.M. (1988) Alterations in developing rat uterine cell populations after neonatal exposure to estrogens and antiestrogens. Teratology, 38, 271-279.
18. Iguchi, T., Todoroki, R., Yamaguchi, S. and Takasugi, N. (1989) Changes in the uterus and vagina of mice treated neonatally with antiestrogens. Acta Anat., 136, 146-154.
19. Iguchi, T., Hirokawa, M. and Takasugi, N. (1986) Occurrence of genital tract abnormalities and bladder hernia in female mice exposed neonatally to tamoxifen. Toxicology, 42, 1-11.
20. Forsberg, J.G (1985) Treatment with different antiestrogens in the neonatal period and effects in the cervicovaginal epithelium and ovaries of adult mice: a comparison to estrogen-induced changes. Biol. Reprod., 32, 427-441.
21. Newbold, R.R., Bullock, B.C., Jefferson, W.N. and Padilla-Burgos, E. (1996) Effects of developmental exposure of mice to tamoxifen. Proc. Am. Assoc. Cancer Res., 37, 109 (Abstract #753).
22. Pasqualini, J.R., Giambiagi, N., Sumida, C., Nguyen, B.L., Gelly, C., Mayrand, C. and Lecerf, F. (1986) Biological responses of tamoxifen in the fetal and newborn vagina and uterus of the guinea-pig and in the R-27 mammary cancer cell line. J. Steroid Biochem., 24, 99-108.
23. McLachlan, J.A., Newbold, R.R. and Bullock, B.C. (1980) Long-term effects on the female mouse genital tract associated with prenatal exposure to diethylstilbestrol. Cancer Res., 40, 3988-3999.
24. Newbold, R.R. and McLachlan, J.A. (1982) Vaginal adenosis and adenocarcinoma in mice exposed prenatally or neonatally to diethylstilbestrol. Cancer Res., 42, 2003-2011.
25. Newbold, R.R., Bullock, B.C. and McLachlan, J.A. (1990) Uterine adenocarcinoma in mice following developmental treatment with estrogens: a model for hormonal carcinogenesis. Cancer Res., 50, 7677-7681.
26. Vancutsem, P.M. and Williams, G.M. (1993) Tamoxifen and teratogenicity in animals. Lancet, 342, 873-874.
27. Mittendorf, R. (1995) Teratogen update: Carcinogenesis and teratogenesis associated with exposure to diethylstilbestrol (DES) in uteri. Teratology, 51, 435-445.
28. Cunha, G.R., Taguchi, O., Namikawa, R., Nishizuka, T. and Robboy, S.J. (1987) Teratogenic effects of clomiphene, tamoxifen, and diethylstilbestrol on the developing human female genital tract. Hum. Pathol., 18, 1132-1143.
29. White, I.N.H., de Matteis, F., Davies, A., Smith, L.L., Crofton-Sleigh, C., Venitt, S., Hewer, A. and Phillips, D.H. (1992) Genotoxic potential of tamoxifen and analogues in female Fischer F344/n rats, DBA/2 and C57B1/6 mice and in human MCL-5 cells. Carcinogenesis, 13, 2197-2203.
30. Uesugi, Y., Sato, T. and Iguchi, T. (1993) Morphometric analysis of the pelvis in mice treated neonatally with tamoxifen. Anat. Rec., 235, 126-130.
31. Hines, M., Alsum, P., Roy, M., Gorski, R. and Goy, R. (1987) Estrogenic contributions to sexual differentiation in the female guinea pig: influences of diethylstilbestrol and tamoxifen on neural, behavioral, and ovarian development. Hormones and Behavior, 21, 402-417.
32. Newbold, R.R. and McLachlan, J.A. (1986) Effects of perinatal exposure to diethylstilbestrol on oviductal development. In Siegler, A.M. (ed.) The Fallopian Tube: Basic Studies and Clinical Contributions. Futura Publishing Company, New York, pp. 179-189.
33. Newbold, R.R., Bullock, B.C. and McLachlan, J.A. (1993) Diverticulosis and salpingitis isthmica noda (SIN) of the fallopian tube: estrogen-induced diverticulosis and SIN of the mouse oviduct. In Copen, C.C., Migaki, G. and Johnson, L.K. (eds) Handbook: Animal Models of Human Disease, Fasc. 19. Registry of Comparative Pathology, Armed Forces Institute of Pathology, Washington, DC.
34. Takamatsu, Y., Iguchi, T. and Takasugi, N. (1992) Effects of postpubertal treatment with diethylstilbestrol and tamoxifen on protein expression in the vagina and uterus of neonatally diethylstilbestrol-exposed mice. In Vivo, 6, 271-278.
35. Carthew, P.L., Edwards, R.E., Nolan, B.M., Martin, E.A. and Smith, L.L. (1996) Tamoxifen associated uterine pathology in rodents: relevance to women. Carcinogenesis, 17, 1577-1582.
36. Iguchi, T. and Takasugi, N. (1986) Polyovular follicles in the ovary of immature mice exposed prenatally to diethylstilbestrol. Anat. Embryol., 175, 53-55.
37. Hemminki, K., Rojaniemi, H., Lindahl, B. and Moberger, B. (1996) Tamoxifen-induced DNA adducts in endometrial samples from breast cancer patients. Cancer Res., 56, 4374-4377.
38. Carmichael, P.L., Ugwumadu, A.H.N., Neven, P., Hewer, A.J., Poon, G.K. and Phillips, D.H. (1996) Lack of genotoxicity of tamoxifen in human endometrium. Cancer Res., 56, 1475-1479.
39. Greco, T.L., Duello, T.M. and Gorski, J. (1993) Estrogen receptors, estradiol, and diethylstilbestrol in early development: the mouse as a model for the study of estrogen receptors and estrogen sensitivity in embryonic development of male and female reproductive tracts. Endocrin Rev., 14, 59-71.
40. Newbold, R.R. (1997) Influence of estrogenic agents on mammalian development in the male. In Korach, K. (ed.) Reproductive and Developmental Toxicology. Marcel Dekker, New York, pp. 533-553.
41. Sato, T., Ohta, Y., Okamura, H., Hayashi, S., Iguchi, T. (1996) Estrogen receptor (ER) and its messenger ribonucleic acid expression in the genital tract of female mice exposed neonatally to tamoxifen and diethylstilbestrol, Anat. Rec., 244, 374-385.